| Stage | SNA | % of rev | CIX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.3B | 100.00% | $44M | 100.00% | SNA ×29.40 |
| Gross profit | $702M | 54.76% | $16M | 35.62% | SNA +19.1pp |
| Operating income | $316M | 24.67% | $9M | 20.45% | SNA +4.2pp |
| Pre-tax income | $319M | 24.90% | $10M | 21.97% | SNA +2.9pp |
| Net income | $250M | 19.47% | $7M | 16.65% | SNA +2.8pp |
| Stage | SNA | CIX | Gap · A − B |
|---|---|---|---|
| Revenue | $1.3B100.00% | $44M100.00% | SNA ×29.40 |
| Gross profit | 54.76%$702M | 35.62%$16M | SNA +19.1pp |
| Operating income | 24.67%$316M | 20.45%$9M | SNA +4.2pp |
| Pre-tax income | 24.90%$319M | 21.97%$10M | SNA +2.9pp |
| Net income |
None
No disclosed counterparties: SNA.
| 19.47%$250M |
| 16.65%$7M |
| SNA +2.8pp |